Sr Director, Quality Large Molecule
Thermo Fisher ScientificSalary not specified
- Full Time
- Expert & Leadership (9+ years)
Not SpecifiedCompensation
Senior (5 to 8 years), Mid-level (3 to 4 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceutical ManufacturingIndustries
Requirements
Candidates should possess a Bachelor’s degree in a scientific discipline, such as Chemistry, Chemical Engineering, or a related field, and hold a minimum of 10 years of experience in pharmaceutical manufacturing, with at least 5 years in a leadership role within a cGMP environment. Strong experience with solid oral dosage form manufacturing, including aseptic processing and sterile manufacturing, is required. Demonstrated leadership skills and the ability to build and manage high-performing teams are essential.
Responsibilities
The Senior Director will oversee all drug product manufacturing activities for the P3 manufacturing facility, ensuring timely completion of technical transfers, development activities, Phase 3 clinical manufacturing, and future commercial production of oral solid dosage products. They will develop and implement manufacturing strategies, build strategic relationships with internal BMS partners, and drive initiatives to improve Process Unit performance. Additionally, the Senior Director will be responsible for creating a cohesive team, fostering a flexible and agile mindset, and partnering with site leadership to establish operational goals and culture while ensuring seamless transition from development to commercialization.
Skills
cGMP
Solid Oral Dosage Form
Aseptic Processing
Sterile Manufacturing
Manufacturing Strategy
Technical Transfer
Clinical Manufacturing
Process Unit Performance
Bristol-Myers Squibb
Develops and delivers biopharmaceutical medicines
About Bristol-Myers Squibb
Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.
Key Metrics
New York City, New YorkHeadquarters
1887Year Founded
$33,706.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees